Ali Rıza Uçar

ORCID: 0000-0003-1812-1911
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Diseases and Glomerulopathies
  • Renal Transplantation Outcomes and Treatments
  • COVID-19 Clinical Research Studies
  • Cytomegalovirus and herpesvirus research
  • Polyomavirus and related diseases
  • Systemic Sclerosis and Related Diseases
  • Cardiac, Anesthesia and Surgical Outcomes
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Chronic Kidney Disease and Diabetes
  • Enhanced Recovery After Surgery
  • Vasculitis and related conditions
  • Lysosomal Storage Disorders Research
  • SARS-CoV-2 and COVID-19 Research
  • Organ Transplantation Techniques and Outcomes
  • Renal and Vascular Pathologies
  • Pregnancy and Medication Impact
  • Abdominal Surgery and Complications
  • Long-Term Effects of COVID-19
  • Hepatitis C virus research
  • Hemoglobinopathies and Related Disorders
  • Neurological Complications and Syndromes
  • Pharmacological Receptor Mechanisms and Effects
  • Autoimmune Bullous Skin Diseases
  • Parvovirus B19 Infection Studies
  • Acute Kidney Injury Research

Istanbul University
2017-2022

Abstract Introduction Management of COVID‐19 in kidney transplant recipients should include treatment the infection, regulation immunosuppression, and supportive therapy. However, there is no consensus on this issue yet. This study aimed to our experiences with diagnosed COVID‐19. Material Methods Kidney from five major centers Istanbul, Turkey, were included retrospective cohort study. Patients classified as having moderate or severe pneumonia for analysis. The primary endpoint was...

10.1111/tid.13371 article EN Transplant Infectious Disease 2020-07-13

BACKGROUND Cytomegalovirus (CMV) and BK virus (BKV) are post-transplant opportunistic viral infections that affect patient graft survival. This study was designed to evaluate the risk of BKV nephropathy CMV disease in kidney transplant recipients who received induction therapy with ATG or basiliximab. MATERIAL AND METHODS We retrospectively analyzed information on 257 adult patients underwent transplantation between January 2007 2017. Patients were categorized into 3 groups according...

10.12659/aot.915885 article EN Annals of Transplantation 2019-07-12

<b><i>Background:</i></b> Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from lack of alpha-galactosidase A (AGALA) activity in lysosomes. <b><i>Objective:</i></b> In this multicenter study, we aimed to evaluate the prevalence FD renal transplant (Tx) recipients Turkey. We also screened dialysis patients as a control group. <b><i>Methods:</i></b> All Tx and were regardless presence primary...

10.1159/000496620 article EN ˜The œNephron journals/Nephron journals 2019-01-01

The prognostic factors for COVID-19 in patients with chronic kidney disease (CKD) are uncertain. We conducted a study to compare clinical and features between hospitalized without CKD.Fifty-six stage 3-5 CKD propensity score-matched fifty-six were included the study. Patients followed-up at least fifteen days or until death after diagnosis. endpoints from all causes, development of acute injury (AKI) cytokine release syndrome respiratory failure, admission intensive care unit (ICU).All...

10.1007/s11255-021-02783-0 article EN other-oa International Urology and Nephrology 2021-02-06

Coronavirus disease 2019 (COVID-19) is a global health problem, but optimal treatment modality unclear. The protocol for patients with COVID-19 consists of azithromycin, hydroxychloroquine (HCQ), and low-molecular-weight heparin in our center. Also, we prescribe oseltamivir until the return influenza test results. Initially, HCQ was administered to all 5 days 10 (400 mg twice day as loading dose on first then 200 maintenance next 4 9 days), without renal adjustments, according insufficient...

10.1016/j.ekir.2020.06.039 article EN cc-by-nc-nd Kidney International Reports 2020-07-12

New PET-positive lesions in previously treated patients with lymphomatous malignancies need further investigations. Relapse, sarcoidosis and secondary are the most important differential diagnosis. Inflammatory myofibroblastic tumors (IMT) is a rare complication after treatment of Hodgkin's disease every lesion should be biopsied to prevent unnecessary intervention.

10.1002/ccr3.976 article EN cc-by-nc-nd Clinical Case Reports 2017-05-04

Abstract Background: It is imperative to closely monitor patients for adverse effects of immunosuppressive (IS) agents, widely used in treating glomerulonephritis (GN). Our study aimed investigate the occurrence any drug-related events with primary GN, explicitly focusing on IS. Methods: The present analyzed 162 adult GN treated IS drugs. scrutinized demographic and clinical profiles patients, laboratory findings, side associated We further investigated frequency nature infections,...

10.18614/deutip.1423356 article EN Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi 2024-09-16

Background We aimed to evaluate the features of primary membranous nephropathy (MNP) in Turkish people.Methods This is a retrospective analysis patients with biopsy-proven MNP. obtained data collected between 2009 and 2019 glomerulonephritis registry Society Nephrology Glomerular Diseases Study Group (TSN-GOLD). Patients secondary cause for MNP were excluded. Clinical, demographic, laboratory, histopathological findings analyzed.Results A total 995 included analyses. Males constituted...

10.1080/0886022x.2022.2079526 article EN cc-by Renal Failure 2022-07-04

Abstract Background and Aims Membranous nephropathy (MN) is the most common cause of glomerulonephritis in non-diabetic adults. B-cell dysfunction an important pathway involved pathogenesis. We, therefore, investigated effects rituximab (RTX) on outcome patients with relapsed or refractory primary MN. Method In this retrospective analysis, 48 MN were evaluated. Patients, who had biopsy-proven disease, a nephrotic-range proteinuria despite at least six months prior immunosuppressive therapy...

10.1093/ndt/gfaa142.p0353 article EN Nephrology Dialysis Transplantation 2020-06-01

The Anatolian Journal of Family Medicine is an international periodical on family medicine and primary health care, published three times a year independent, unbiased, double-blinded peer-review principles.

10.5505/anatoljfm.2021.32154 article EN cc-by-nc-nd The Anatolian Journal of Family Medicine 2021-01-01
Coming Soon ...